Events

Join us for upcoming events at the ASU Biodesign Institute.

A Sip of Science

A Sip of Science features science-relevant discussions between community members and our experts.

The series debuted in 2018 and was named “Best Way to Drink and Learn” in the Best of Phoenix 2020 listing by Phoenix New Times. This year, we are going virtual. With ingredients at the ready, prepare a drink or appetizer alongside a well-known, local mixologist or chef right from your own kitchen or couch. No space constraints, no drive-time, no hassles just happy hour fun!

Upcoming events

New dates for Fall 2022 planned. Details to be announced.

Previous events

Discovery Series

The Discovery Series, launched in 2013, brings eminent scientists, thought leaders and innovators from around the world to the Biodesign Institute to share their research expertise.

Discovery Series lectures and interactive discussions which follow exposes our faculty, staff and students to the latest developments in science, technology and medicine, keeping Biodesign researchers abreast of current trends and breakthroughs. Discovery Series events also provide networking and collaborative research opportunities. Lectures are open to the community. Seating available on a first-come, first-served basis. Please join us!

Upcoming lectures

There are currently no upcoming speakers.

Past lectures

Understanding the Electronic Properties of Biomolecules

December 15, 2021 5:19 pm

Cyclic dinucleotide signaling: New antibacterial and immunomodulatory therapeutics

June 29, 2022 5:02 pm

Karen Szumlinski, PhD, Professor, Department of Molecular, Cellular and Developmental Biology & Neuroscience Research Insitute at University of California, Santa Barbara. Recorded April 20, 2022. 

Substance use disorder is a chronic, relapsing, neuropsychiatric condition that affects 2% of the world’s population.  Substance use disorder is the leading risk factor of premature death globally. In addition to the deaths directly attributed to drug over-dose or fatal accidents, substance use increases the risk for many types of cancers, in addition to cardiovascular, metabolic, renal, and hepatic diseases, neurodevelopmental and neurodegenerative disorders, various neuropsychiatric conditions and suicide, accounting for 3-5% of the disease burden in many Western countries. 

The work to be discussed in this talk seeks to identify the environmental, genetic, age- and sex-related determinants of alcohol, opioid, and psychostimulant use vulnerability, as well as their co-morbidity with affective, neurocognitive and eating disorders. Using rodent models, we have distinguished between the neurobiological impact of various addictive substances of relevance to the design of substance-specific therapy. We are exploring and validating the therapeutic potential of drugs already approved by the FDA for other uses for neuroimmune modulation as an approach to reduce drug-taking and craving.

The Discovery Series, launched in 2013, brings eminent scientists, thought leaders and innovators from around the world to the Biodesign Institute to share their research expertise.  Discovery Series lectures and interactive discussions which follow exposes our faculty, staff and students to the latest developments in science, technology and medicine, keeping Biodesign researchers abreast of current trends and breakthroughs.  

The Biodesign Institute at ASU delivers the future of nature-inspired scientific innovation today for the betterment of human health, community safety and global sustainability.

Karen Szumlinski, PhD, Professor, Department of Molecular, Cellular and Developmental Biology & Neuroscience Research Insitute at University of California, Santa Barbara. Recorded April 20, 2022.

Substance use disorder is a chronic, relapsing, neuropsychiatric condition that affects 2% of the world’s population. Substance use disorder is the leading risk factor of premature death globally. In addition to the deaths directly attributed to drug over-dose or fatal accidents, substance use increases the risk for many types of cancers, in addition to cardiovascular, metabolic, renal, and hepatic diseases, neurodevelopmental and neurodegenerative disorders, various neuropsychiatric conditions and suicide, accounting for 3-5% of the disease burden in many Western countries.

The work to be discussed in this talk seeks to identify the environmental, genetic, age- and sex-related determinants of alcohol, opioid, and psychostimulant use vulnerability, as well as their co-morbidity with affective, neurocognitive and eating disorders. Using rodent models, we have distinguished between the neurobiological impact of various addictive substances of relevance to the design of substance-specific therapy. We are exploring and validating the therapeutic potential of drugs already approved by the FDA for other uses for neuroimmune modulation as an approach to reduce drug-taking and craving.

The Discovery Series, launched in 2013, brings eminent scientists, thought leaders and innovators from around the world to the Biodesign Institute to share their research expertise. Discovery Series lectures and interactive discussions which follow exposes our faculty, staff and students to the latest developments in science, technology and medicine, keeping Biodesign researchers abreast of current trends and breakthroughs.

The Biodesign Institute at ASU delivers the future of nature-inspired scientific innovation today for the betterment of human health, community safety and global sustainability.

YouTube Video UExDSUxwMmlxTXpqWHlZeFRnOVpIV09UMjRWaHBVOFZpMi4wOTA3OTZBNzVEMTUzOTMy

Substance use disorder: A global problem requiring an effective translational medicine approach

June 29, 2022 5:02 pm

Arntzen Grand Challenges

The Arntzen Grand Challenges Lecture series is inspired by Dr. Charles (Charlie) Arntzen, Founding Director of the ASU Biodesign Institute.

Dr. Arntzen is internationally recognized for his novel applied research on the development of genetic strategies for using plants to manufacture pharmaceuticals and produce cost-effective vaccines or drugs to save lives around the world, especially in developing nations.

Upcoming lectures

There are currently no upcoming speakers.

Past lectures

Britt Glaunsinger, PhD, Professor, Departments of Plant & Microbial Biology and Molecular & Cellular Biology, University of California, Berkeley; Class of 1963 Endowed Chair, University of California, Berkeley; HHMI Investigator, Howard Hughes Medical Institute. Recorded Oct. 29, 2020

The coronavirus pandemic has upended society and dramatically changed the face of scientific research. This unprecedented global shift towards the singular goal of understanding how this novel coronavirus works and how to stop it has contributed to a remarkably rapid and deep understanding of the viral lifecycle. In this context, Glaunsinger will describe the latest findings on how SARS-CoV-2 slips past our cells’ barriers, hijacks the cellular machinery, is amplified to form new progeny virions and escapes detection by the immune system. Glaunsinger will also highlight the viral components that are targets for therapeutic interventions and vaccine design, whose degrees of success may ultimately define the duration of this pandemic.

The Arntzen Grand Challenges Lecture series is inspired by Dr. Charles (Charlie) Arntzen, Founding Director of the ASU Biodesign Institute. Dr. Arntzen is internationally recognized for his novel applied research on the development of genetic strategies for using plants to manufacture pharmaceuticals and produce cost-effective vaccines or drugs to save lives around the world, especially in developing nations.

The Biodesign Institute at ASU delivers the future of nature-inspired scientific innovation today for the betterment of human health, community safety and global sustainability.

Follow us on our social media channels:
Facebook: https://www.facebook.com/ASUBiodesign
Twitter: https://twitter.com/ASUBiodesign
Instagram: https://www.instagram.com/asubiodesign
LinkedIn: https://www.linkedin.com/company/asu-biodesign-institute

Britt Glaunsinger, PhD, Professor, Departments of Plant & Microbial Biology and Molecular & Cellular Biology, University of California, Berkeley; Class of 1963 Endowed Chair, University of California, Berkeley; HHMI Investigator, Howard Hughes Medical Institute. Recorded Oct. 29, 2020

The coronavirus pandemic has upended society and dramatically changed the face of scientific research. This unprecedented global shift towards the singular goal of understanding how this novel coronavirus works and how to stop it has contributed to a remarkably rapid and deep understanding of the viral lifecycle. In this context, Glaunsinger will describe the latest findings on how SARS-CoV-2 slips past our cells’ barriers, hijacks the cellular machinery, is amplified to form new progeny virions and escapes detection by the immune system. Glaunsinger will also highlight the viral components that are targets for therapeutic interventions and vaccine design, whose degrees of success may ultimately define the duration of this pandemic.

The Arntzen Grand Challenges Lecture series is inspired by Dr. Charles (Charlie) Arntzen, Founding Director of the ASU Biodesign Institute. Dr. Arntzen is internationally recognized for his novel applied research on the development of genetic strategies for using plants to manufacture pharmaceuticals and produce cost-effective vaccines or drugs to save lives around the world, especially in developing nations.

The Biodesign Institute at ASU delivers the future of nature-inspired scientific innovation today for the betterment of human health, community safety and global sustainability.

Follow us on our social media channels:
Facebook: https://www.facebook.com/ASUBiodesign
Twitter: https://twitter.com/ASUBiodesign
Instagram: https://www.instagram.com/asubiodesign
LinkedIn: https://www.linkedin.com/company/asu-biodesign-institute

YouTube Video UExDSUxwMmlxTXpqVmJNYTA4elRsQVZkWVFzMFlGSEZXbi41NkI0NEY2RDEwNTU3Q0M2

Arntzen Grand Challenges Lecture 2020: Understanding and combatting the pandemic coronavirus

October 30, 2020 7:24 pm

Presented by Zachary S. Rogers, PhD, Assistant Professor, Operations and Supply Chain Management, Colorado State University. Recorded on Nov. 2, 2021.

For years, global supply chains expanded and became increasingly complex in a quest to make shipping goods and services around the globe cheaper and faster. COVID-19 threw these finely tuned systems into tail-spin, making it difficult to find everything from toilet paper to pickup trucks. This disruption was not the first, nor will it be the last - but it has led to new ways of thinking that may lead to significant changes in the coming decades. There will be great change, but also great opportunity for innovation and connection. Zachary Rogers will share what's next and how it will impact your life, availability of everyday goods, personal data and the world economy.

The Arntzen Grand Challenges Lecture series is inspired by Dr. Charles (Charlie) Arntzen, Founding Director of the ASU Biodesign Institute. Dr. Arntzen is internationally recognized for his novel applied research on the development of genetic strategies for using plants to manufacture pharmaceuticals and produce cost-effective vaccines or drugs to save lives around the world, especially in developing nations.

The Biodesign Institute at ASU delivers the future of nature-inspired scientific innovation today for the betterment of human health, community safety and global sustainability.

Presented by Zachary S. Rogers, PhD, Assistant Professor, Operations and Supply Chain Management, Colorado State University. Recorded on Nov. 2, 2021.

For years, global supply chains expanded and became increasingly complex in a quest to make shipping goods and services around the globe cheaper and faster. COVID-19 threw these finely tuned systems into tail-spin, making it difficult to find everything from toilet paper to pickup trucks. This disruption was not the first, nor will it be the last – but it has led to new ways of thinking that may lead to significant changes in the coming decades. There will be great change, but also great opportunity for innovation and connection. Zachary Rogers will share what's next and how it will impact your life, availability of everyday goods, personal data and the world economy.

The Arntzen Grand Challenges Lecture series is inspired by Dr. Charles (Charlie) Arntzen, Founding Director of the ASU Biodesign Institute. Dr. Arntzen is internationally recognized for his novel applied research on the development of genetic strategies for using plants to manufacture pharmaceuticals and produce cost-effective vaccines or drugs to save lives around the world, especially in developing nations.

The Biodesign Institute at ASU delivers the future of nature-inspired scientific innovation today for the betterment of human health, community safety and global sustainability.

YouTube Video UExDSUxwMmlxTXpqVmJNYTA4elRsQVZkWVFzMFlGSEZXbi4yODlGNEE0NkRGMEEzMEQy

Arntzen Grand Challenge 2021: COVID-19 and the 2021 Global Supply Chain Crisis

November 5, 2021 1:21 pm

Subscribe to our newsletter

Learn more about events like these and stay up-to-date on our latest discoveries by signing up for our email newsletter.